Journal of Nutrition and Health

  • 제37권9호
  • /
  • Pages.786-793
  • /
  • 2004
  • /
  • 2288-3886(pISSN)
  • /
  • 2288-3959(eISSN)
한국영양학회 (The Korean Nutrition Society)
권호 표지

난소절제와 Genistein 투여가 간 미토콘드리아 기능에 미치는 영향

Effect of Ovariectomy and Genistein on Hepatic Mitochondrial Function

  • 이영민 (국립보건연구원 생명의학부 대사영양질환과, 서울대학교 식품영양학과) ;
  • 정명호 (국립보건연구원 생명의학부 대사영양질환과) ;
  • 이연숙 (서울대학교 식품영양학과) ;
  • 송지현 (국립보건연구원 생명의학부 대사영양질환과)
  • 발행 : 2004.11.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Women with menopause or rats with ovariectomy is associated with increased body weight, body fat and insulin resistance, which are components of metabolic syndrome. Increased prevalence of metabolic syndrome after menopause might be associated with mitochondrial dysfunction, since mitochondrial oxidative and phosphorylation activity is strongly correlated with insulin sensitivity. Although estradiol replacement prevents the metabolic syndrome, harmful effect of estradiol hampers the casual usage to prevent the metabolic syndrome. It has been reported that genistein has a mild estrogenic activity, decreases fat mass in mice and has an antidiabetic role in diabetic rats. Although insulin resistance is closely related to mitochondrial functions, there has not been yet any study in regard to the effect of dietary genistein on mitochondrial function in the insulin resistant female subjects induced by ovariectomy or similar situation. The present study investigated whether the supplementation of genistein in the high fat diet affected the mitochondrial function of high fat fed ovariectomized rats. Female Sprague Dawley rats (8 weeks old) were assigned to the following groups: sham-operated+ high fat diet (S, n=6); sham-operated + high fat diet with 0.1% genistein (S + G, n=7); ovariectomized + high fat diet (OVX, n=8); ovariectomized + high fat diet with 0.1% genistein (OVX+ G, n=8). Ovariectomy significantly increased body weight compared with S group. Genistein consumption in ovariectomized (OVX + G) rats decreased body weight gain compared with OVX rats. Liver weights were increased by ovariectomy. The hepatic mitochondrial protein density expressed as mg per g liver was lower in the OVX group than in the S group. However, OVX + G group showed the increased mitochondrial protein density similar to the level of S group. When mRNA levels of genes related to mitochondria such as peroxisome proliferator-activated receptor ${\gamma}$ coactivator 1 (PGC-1) and cytochrome c oxidase subunit III (COX III) were measured, there were decreases in the mRNA levels of PGC-1 and COX III in S + G, OVX and OVX + G group. The activity of cytochrome c oxidase was not different between groups. We could observe the decrease in succinate dehydrogenase (SDH) activity per g liver in OVX rats. Genistein supplement increased SDH activity. In conclusion, genistein supplementation to the OVX rats enhanced mitochondrial function by increasing mitochondrial protein density and SDH activity. The improvement in mitochondrial function by genistein can contribute to the improvement in metabolic syndrome.

키워드

참고문헌

  1. Song J, Kim E, Shin C, Kim SS, Lee HK, Jung M, Jung SC, Jo SA, Jo I. Prevalence of the metabolic syndrome among South Korean adults: the Ansan study. Diabet Med 21: 1154-1155, 2004 https://doi.org/10.1111/j.1464-5491.2004.01399.x
  2. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288: 2709-2716, 2002 https://doi.org/10.1001/jama.288.21.2709
  3. Laaksonen DE, Lakka HM, Niskanen LK, Kaplan GA, Salonen JT, Lakka TA. Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol 156: 1070-1077, 2002 https://doi.org/10.1093/aje/kwf145
  4. Carr MC. The Emergence of the Metabolic Syndrome with Menopause. J Clin Endocrinol Metabolism 88 (6) : 2404-2411, 2003 https://doi.org/10.1210/jc.2003-030242
  5. Kannel WB, Levy D. Menopause, hormones, and cardiovascular vulnerability in women. Arch Intern Med 164 (5) : 479-481, 2004 https://doi.org/10.1001/archinte.164.5.479
  6. Relimpio F, Martinez-Brocca MA, Leal-Cerro A, Losada F, Mangas MA, Pumar A, Astorga R. Variability in the presence of the metabolic syndrome in Type 2 diabetic patients attending a diabetes clinic: Influences of age and gender. Diabetes Res Clin Pract 65(2) : 135-142, 2004 https://doi.org/10.1016/j.diabres.2003.12.003
  7. Bowles D. A Radical idea: men and women are different. Cardiovasc Res 61 (1) : 5-6, 2004 https://doi.org/10.1016/j.cardiores.2003.11.006
  8. Abelenda M, Puerta M. Dual control of cytochrome-c oxidase activity by female sex steroids. Eur J Endocrinol 141 (6) : 630-636, 1999 https://doi.org/10.1530/eje.0.1410630
  9. Borras C, Sastre J, Garcia-Sala D, Lloret A, Pallardo FV, Vina J. Mitochondria from females exhibit higher antioxidant gene expression and lower oxidative damage than males. Free Radic Biol Med 34 (5) : 546-552, 2003 https://doi.org/10.1016/S0891-5849(02)01356-4
  10. Nicholls DG. Mitochondrial function and dysfunction in the cell: its relevance to aging and aging-related disease. Int J Biochem Cell Biol 34(11) : 1372-1381, 2002 https://doi.org/10.1016/S1357-2725(02)00077-8
  11. Wallace DC. Mitochondrial diseases in man and mouse. Science 283 (5407): 1482-1488, 1999 https://doi.org/10.1126/science.283.5407.1482
  12. Wallace DC. Mitochondrial DNA sequence variation in human evolution and disease. Proc Natl Acad Sci USA 91 (19): 8739-8746, 1994 https://doi.org/10.1073/pnas.91.19.8739
  13. Mootha VK, Bunkenborg J, Olsen JV, Hjerrild M, Wisniewski JR, Stahl E, Bolouri MS, Ray HN, Sihag S, Kamal M, Patterson N, Lander ES, Mann M. Integrated analysis of protein composition, tissue diversity, and gene regulation in mouse mitochondria. Cell 115 (5) : 629-640, 2003 https://doi.org/10.1016/S0092-8674(03)00926-7
  14. Venkatraman A, Landar A, Davis AJ, Chamlee L, Sanderson T, Kim H, Page G, Pompilius M, Ballinger S, Darley-Usmar V, Bailey SM. Modification of the mitochondrial proteome in response to the stress of ethanol-dependent hepatotoxicity. J Bioi Chem 279 (21): 22092-22101, 2004 https://doi.org/10.1074/jbc.M402245200
  15. Short KR, Nair KS, Stump CS. Impaired Mitochondrial Activity and Insulin Resistant Offspring of Patients with Type 2 Diabetes. N Engl J Med 350(23): 2419-2421, 2004 https://doi.org/10.1056/NEJM200406033502320
  16. Lambert AJ, Wang B, Yardley J, Edwards J, Merry BJ. The effect of aging and caloric restriction on mitochondrial protein density and oxygen consumption. Exp Gerontol 39 (3) : 289-295, 2004 https://doi.org/10.1016/j.exger.2003.12.009
  17. Barnes S. Soy isoflavones-phytoestrogens and what else? J Nutr 134(5) : 1225S-1228S, 2004
  18. Naaz A, Yellayi S, Zakroczymski MA, Bunick D, Doerge DR, Lubahn DB, Helferich WG, Cooke PS. The soy isoflavone genistein decreases adipose deposition in mice. Endocrinology 144 (8): 3315-3320, 2003 https://doi.org/10.1210/en.2003-0076
  19. Mezei O, Banz WJ, Steger RW, Peluso MR, Winters TA, Shay N. Soy isoflavones exert antidiabetic and hypolipidemic effects through the PPAR pathways in obese Zucker rats and murine RAW 264.7 cells. J Nutr 133 (5): 1238-1243, 2003
  20. Johnson D, Lardy H. Isolation of liver or kidney mitochondria. In: Methods in enzymology vol 10. Oxidation and phosphorylation (Estabrook RW & Pullman ME eds) pp.94-96, NY, Academic Press, 1967 https://doi.org/10.1016/0076-6879(67)10018-9
  21. Cwen P, Freer JH. Factors influencing the activity of succinate dehydrogenase in membrane preparations from Micrococcus Iysodeikticus. Biochem J 120: 237-243, 1970
  22. Wharton DC, Tzogaloff A. Cytochrome oxidase from beef heart mitochondria In: Methods in enzymolgy Vol 10, Oxidation and phosphorylation (Estabrook RW & Pullman ME eds) pp.245-247, NY. Academic Press. 1967 https://doi.org/10.1016/0076-6879(67)10048-7
  23. Peinnequin A, Mouret C, Birot O, Alonso A, Mathieu J, Clarencon D, Agay D, Chancerelle Y, Multon E. Rat pro-inflammatory cytokine and cytokine related mRNA quantification by real-time polymerase chain reaction using SYBR green. BMC Immunol 5 (1): 3-12, 2004 https://doi.org/10.1186/1471-2172-5-3
  24. Meli R, Pacilio M, Raso GM, Esposito E, Coppola A, Nasti A, Di Carlo C, Nappi C, Di Carlo R. Estrogen and raloxifene modulate leptin and its receptor in hypothalamus and adipose tissue from ovariectomized rats. Endocrinology 145 (7): 3115-3121, 2004 https://doi.org/10.1210/en.2004-0129
  25. Lemieux C, Picard F, Labrie F, Richard D, Deshaies Y. The estrogen antagonist EM-652 and dehydroepiandrosterone prevent diet- and ovariectomy-induced obesity. Obes Res 11 (3) : 477-490, 2003 https://doi.org/10.1038/oby.2003.65
  26. Okazaki K, Okazaki S, Nakamura H, Kitamura Y, Hatayama K, Wakabayashi S, Tsuda T, Katsumata T, Nishikawa A, Hirose M. A repeated 28-day oral dose toxicity study of genistein in rats, based on the 'Enhanced OECD Test Guideline 407' for screening endocrine-disrupting chemicals. Arch ToxicoI 76(10): 553-559, 2002 https://doi.org/10.1007/s00204-002-0376-0
  27. Scarpulla RC. Nuclear activators and coactivators in mammalian mitochondrial biogenesis. Biochim Biophys Acta 1576 (1-2): 1-14, 2002
  28. Van Itallie CM, Dannies PS. Estrogen induces accumulation of the mitochondrial ribonucleic acid for subunit II of cytochrome oxidase in pituitary tumor cells. Mol EndocrinoI 2(4) : 332-337, 1988 https://doi.org/10.1210/mend-2-4-332
  29. Au HC, Ream-Robinson D, Bellew LA, Broomfield PL, Saghbini M, Scheffler IE. Structural organization of the gene encoding the human iron-sulfur subunit of succinate dehydrogenase. Gene 159(2) : 249-253, 1995 https://doi.org/10.1016/0378-1119(95)00162-Y